Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jaume Puig-Junoy, Natàlia Pascual-Argente, Lluc Puig-Codina, Laura Planellas & Míriam Solozabal. (2018) Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review. Expert Review of Gastroenterology & Hepatology 12:12, pages 1251-1263.
Read now
Read now
Ivan Gentile, Alberto E. Maraolo, Massimo Niola, Vincenzo Graziano, Guglielmo Borgia & Mariano Paternoster. (2016) Limiting the access to direct-acting antivirals against HCV: an ethical dilemma. Expert Review of Gastroenterology & Hepatology 10:11, pages 1227-1234.
Read now
Read now
Sammy Saab, Hélène Parisé, Suchin Virabhak, Alice Wang, Steven E. Marx, Yuri Sanchez Gonzalez, Derek Misurski & Scott Johnson. (2016) Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US. Journal of Medical Economics 19:8, pages 795-805.
Read now
Read now
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Isabella Esposito, Laura Benítez-Gutiérrez, José M Peña & Pablo Barreiro. (2016) New hepatitis C therapies for special patient populations. Expert Opinion on Pharmacotherapy 17:2, pages 217-229.
Read now
Read now
Articles from other publishers (16)
Taruja Karmarkar, Carla V. Rodriguez-Watson, Eric Watson, Hanke Zheng, Darrell J. Gaskin & William V. Padula. (2022) Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis. Value in Health 25:9, pages 1499-1509.
Crossref
Crossref
Smriti Rajita Kumar, Sameed Ahmed M. Khatana & David Goldberg. (2022) Impact of Medicaid Expansion on Liver-Related Mortality. Clinical Gastroenterology and Hepatology 20:2, pages 419-426.e1.
Crossref
Crossref
Phillip E. Ross, Joseph R. Young, Casey M. O’Connor, Afshin A. Anoushiravani & Matthew R. DiCaprio. (2021) Perioperative Management of Hepatitis C in Patients Undergoing Total Joint Arthroplasty. JBJS Reviews 9:11.
Crossref
Crossref
Chester J. Donnally, Parthik D. Patel, Jose A. Canseco, Kartik Shenoy, Srikanth N. Divi, Vadim Goz, Abdul R. Arain & Alexander R. Vaccaro. (2020) Hepatitis C Virus Infection as a Predictor of Complications and Increased Costs Following Primary Lumbar Fusion Surgery. Spine 45:16, pages E1020-E1025.
Crossref
Crossref
Yu‐Chih Lin, Wen‐Nan Chiu, Te‐Sheng Chang, Tung‐Jung Huang & Mei‐Yen Chen. (2019) Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal. Journal of Nursing Scholarship 52:2, pages 128-135.
Crossref
Crossref
Baek Gyu Jun, Eui Ju Park, Woong Cheul Lee, Jae Young Jang, Soung Won Jeong, Young Don Kim, Gab Jin Cheon, Young Sin Cho, Sae Hwan Lee, Hong Soo Kim, Yun Nah Lee, Sang Gyune Kim, Young Seok Kim & Boo Sung Kim. (2019) Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C. The Korean Journal of Internal Medicine 34:5, pages 989-997.
Crossref
Crossref
Antoine Chaillon, Sanjay R. Mehta, Martin Hoenigl, Sunil S. Solomon, Peter Vickerman, Matthew Hickman, Britt Skaathun & Natasha K. Martin. (2019) Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection. PLOS ONE 14:6, pages e0217964.
Crossref
Crossref
Anupam Bapu Jena, Julia Thornton Snider, Oliver Diaz Espinosa, Andy Ingram, Yuri Sanchez Gonzalez & Darius Lakdawalla. (2019) How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom?. Value in Health 22:6, pages 669-676.
Crossref
Crossref
Hany S. Bedair, Brian M. Schurko, Maureen K. Dwyer, David Novikov, Afshin A. Anoushiravani & Ran Schwarzkopf. (2019) Treatment for Chronic Hepatitis C Prior to Total Hip Arthroplasty Significantly Reduces Periprosthetic Joint Infection. The Journal of Arthroplasty 34:1, pages 132-135.
Crossref
Crossref
X. Li, N. S. Chan, A. W. Tam, I. F. N. Hung & E. W. Chan. (2017) Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases 36:10, pages 1801-1809.
Crossref
Crossref
Eleanor M. Wilson, Elana S. Rosenthal, Sarah Kattakuzhy, Lydia Tang & Shyam Kottilil. (2017) Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C. Clinical Microbiology Reviews 30:1, pages 23-42.
Crossref
Crossref
Pei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, Ming-Lun Yeh, Po-Cheng Liang, Yi-Hung Lin, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang & Ming-Lung Yu. (2017) A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan. The Kaohsiung Journal of Medical Sciences 33:1, pages 44-49.
Crossref
Crossref
Thilo Bracht, Christian M?lleken, Maike Ahrens, Gereon Poschmann, Anders Schlosser, Martin Eisenacher, Kai St?hler, Helmut E. Meyer, Wolff H. Schmiegel, Uffe Holmskov, Grith L. Sorensen & Barbara Sitek. (2016) Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients. Journal of Translational Medicine 14:1.
Crossref
Crossref
Autumn Bagwell & Cody A. Chastain. (2016) Hepatitis C Treatment in HIV Coinfection: Approaches, Challenges, and Future Opportunities. Current Treatment Options in Infectious Diseases 8:4, pages 379-399.
Crossref
Crossref
S.A. Fayek, C. Quintini, K.D. Chavin & C.L. Marsh. (2016) The Current State of Liver Transplantation in the United States. American Journal of Transplantation 16:11, pages 3093-3104.
Crossref
Crossref
Zobair M. Younossi, Aybike Birerdinc & Linda Henry. (2016) Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences. Journal of Hepatology 65:1, pages S109-S119.
Crossref
Crossref